Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208559 · ClinicalTrials.gov registry record · Phase 2
Ziprasidone in Children With Autism: A Pilot Study
A Phase 2 study, sponsored by Drexel University College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT00208559 is a Phase 2 study that has completed, run by Drexel University College of Medicine. The registered enrollment target is 15 participants.
The verdict
NCT00208559, a Phase 2 study, has completed, sponsored by Drexel University College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the drug, ziprasidone, is effective in treating problems in adolescent associated with autism.
Interventions
- DRUG Ziprasidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2002-02 |
| Est. Completion | 2006-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208559
The ClinicalTrials.gov registry entry for NCT00208559 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University College of Medicine, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ziprasidone is the first listed.
NCT00208559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208559 about?
NCT00208559 is a clinical study titled "Ziprasidone in Children With Autism: A Pilot Study". The purpose of this study is to see if the drug, ziprasidone, is effective in treating problems in adolescent associated with autism.
What is the current status of trial NCT00208559?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2002-02. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00208559?
The interventions under investigation include: Ziprasidone (DRUG).
Who is sponsoring clinical trial NCT00208559?
This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.